This article was published more than 20 years ago. Some information may no longer be current.
| Micrologix Biotech Inc. |
| (MBI-TSX) |
|
2Q to Oct. 31 |
Year ago |
| Revenue |
654,000 |
2,295,000 |
| Net profit |
(3,478,000) |
(2,514,000) |
| Net profit/share |
(0.07) |
(0.07) |
| Cash Flow |
(3,310,000) |
(7,311,000) |
| Avg. Shares |
46,691,000 |
38,335,000 |
|
6 months to Oct. 31 |
Year ago |
| Revenue |
2,046,000 |
4,062,000 |
| Net profit |
(6,494,000) |
(3,972,000) |
| Net profit/share |
(0.14) |
(0.10) |
| Cash Flow |
(5,925,000) |
(9,080,000) |
| Avg. Shares |
46,629,000 |
38,311,000 |